| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.063 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |